{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T18:18:38Z","timestamp":1792001918101,"version":"4.4.0"},"reference-count":216,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","croh-online.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Critical Reviews in Oncology\/Hematology"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1016\/j.critrevonc.2016.01.012","type":"journal-article","created":{"date-parts":[[2016,1,19]],"date-time":"2016-01-19T15:41:02Z","timestamp":1453218062000},"page":"332-350","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":269,"special_numbering":"C","title":["Thymoma and thymic carcinomas"],"prefix":"10.1016","volume":"99","author":[{"given":"Marta","family":"Scorsetti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Leo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annalisa","family":"Trama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rolando","family":"D\u2019Angelillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danila","family":"Serpico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianna","family":"Macerelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Zucali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gemma","family":"Gatta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina Chiara","family":"Garassino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.critrevonc.2016.01.012_bib0005","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1038\/ajg.2009.99","article-title":"Transient autoimmune hepatitis induced by a thymoma","volume":"104","author":"Aigner","year":"2009","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.critrevonc.2016.01.012_bib0010","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1097\/JTO.0b013e3181d86a30","volume":"5","author":"Aisner","year":"2010","journal-title":"J. Thorac. Oncol."},{"issue":"4","key":"10.1016\/j.critrevonc.2016.01.012_bib0015","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1080\/02841860802495362","article-title":"Motesanib diphosphate (AMG 706), an oral angiogenesis inhibitor, demonstrates clinical efficacy in advanced thymoma","volume":"48","author":"Azad","year":"2009","journal-title":"Acta Oncol."},{"issue":"Suppl","key":"10.1016\/j.critrevonc.2016.01.012_bib0020","doi-asserted-by":"crossref","first-page":"19087","DOI":"10.1200\/jco.2008.26.15_suppl.19087","article-title":"A Phase II trial of erlotinib plus bevacizumab in patients with recurrent thymoma or thymic carcinoma","volume":"15","author":"Bedano","year":"2008","journal-title":"J. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.critrevonc.2016.01.012_bib0025","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0003-4975(10)63498-4","article-title":"Tumors of the thymus and thymic region. I. clinicopathological studies on thymomas","volume":"25","author":"Bergh","year":"1978","journal-title":"Ann. Thorac. Surg."},{"issue":"15","key":"10.1016\/j.critrevonc.2016.01.012_bib0030","doi-asserted-by":"crossref","first-page":"3502","DOI":"10.1002\/cncr.25851","article-title":"Adjuvant radiotherapy for completely resected stage 2 thymoma","volume":"117","author":"Berman","year":"2011","journal-title":"Cancer"},{"key":"10.1016\/j.critrevonc.2016.01.012_bib0035","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/S0022-5223(20)31934-6","article-title":"A clinicopathological study","volume":"42","author":"Bernatz","year":"1961","journal-title":"J. Thorac. Cardiovasc. Surg."},{"issue":"6","key":"10.1016\/j.critrevonc.2016.01.012_bib0040","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1097\/JTO.0b013e3181a52e25","article-title":"Long lasting response to the multikinase inhibitor bay 43-9006 (Sorafenib) in a heavily pretreated metastatic thymic carcinoma","volume":"4","author":"Bisagni","year":"2009","journal-title":"J. Thorac. Oncol."},{"issue":"4","key":"10.1016\/j.critrevonc.2016.01.012_bib0045","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/0003-4975(95)00669-C","article-title":"Thymoma: a multivariate analysis of factors predicting survival","volume":"60","author":"Blumberg","year":"1995","journal-title":"Ann. Thorac. Surg."},{"issue":"4","key":"10.1016\/j.critrevonc.2016.01.012_bib0050","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1097\/00000421-199308000-00014","article-title":"EST 2582 phase II trial of cisplatin in metastatic or recurrent thymoma","volume":"16","author":"Bonomi","year":"1993","journal-title":"Am. J. Clin. Oncol."},{"issue":"33","key":"10.1016\/j.critrevonc.2016.01.012_bib0055","doi-asserted-by":"crossref","first-page":"e803","DOI":"10.1200\/JCO.2011.36.6427","article-title":"Impressive response with imatinib in a heavily pretreated patient with metastatic c-KIT mutated thymic carcinoma","volume":"29","author":"Buti","year":"2011","journal-title":"J. Clin. Oncol."},{"issue":"4","key":"10.1016\/j.critrevonc.2016.01.012_bib0060","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/0046-8177(91)90083-2","article-title":"Tumors of the neck showing thymic or related branchial pouch differentiation: a unifying concept","volume":"22","author":"Chan","year":"1991","journal-title":"Hum. Pathol."},{"issue":"7","key":"10.1016\/j.critrevonc.2016.01.012_bib0065","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1097\/JTO.0b013e31821f9662","article-title":"Postoperative radiotherapy for completely resected stage II or III thymoma","volume":"6","author":"Chang","year":"2011","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.critrevonc.2016.01.012_bib0070","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/S0046-8177(96)90289-0","article-title":"Detection of bcl-2 and p53 in thymoma: expression of bcl-2 as a reliable marker of tumor aggressiveness","volume":"27","author":"Chen","year":"1996","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.critrevonc.2016.01.012_bib0075","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1002\/cncr.10665","article-title":"New WHO histologic classification predicts prognosis of thymic epithelial tumors: a clinicopathologic study of 200 thymoma cases from China","volume":"95","author":"Chen","year":"2002","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.critrevonc.2016.01.012_bib0080","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1007\/s00595-006-3383-6","article-title":"Characteristics of thymoma successfully resected by videothoracoscopic surgery","volume":"37","author":"Chen","year":"2007","journal-title":"Surg. Today"},{"issue":"5","key":"10.1016\/j.critrevonc.2016.01.012_bib0085","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1016\/j.ijrobp.2009.09.066","article-title":"Role of adjuvant radiotherapy for stage II thymoma after complete tumor resection","volume":"78","author":"Chen","year":"2010","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"10","key":"10.1016\/j.critrevonc.2016.01.012_bib0090","doi-asserted-by":"crossref","first-page":"3750","DOI":"10.1158\/1078-0432.CCR-04-1981","article-title":"Mutation in the tyrosine kinase domain of epidermal growth factor receptor is a predictive and prognostic factor for gefitinib treatment in patients with non-small cell lung cancer","volume":"11","author":"Chou","year":"2005","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.critrevonc.2016.01.012_bib0095","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1093\/annonc\/mdn388","article-title":"Response of malignant thymoma to erlotinib","volume":"19","author":"Christodoulou","year":"2008","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.critrevonc.2016.01.012_bib0100","doi-asserted-by":"crossref","first-page":"e56","DOI":"10.1200\/JCO.2006.08.8963","article-title":"Dasatinib induces a response in malignant thymoma","volume":"24","author":"Chuah","year":"2006","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2016.01.012_bib0105","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1200\/JCO.1994.12.7.1484","article-title":"Prognostic factors and outcome of incompletely resected invasive thymoma following radiation therapy","volume":"12","author":"Ciernik","year":"1994","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2016.01.012_bib0110","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.aanat.2007.05.003","article-title":"Immunohistochemical expression of vascular endothelial growth factor A (VEGF), and its receptors (VEGFR1, 2) in normal and pathologic conditions of the human thymus","volume":"190","author":"Cimpean","year":"2008","journal-title":"Ann. Anat."},{"issue":"4","key":"10.1016\/j.critrevonc.2016.01.012_bib0115","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1177\/106689690401200412","article-title":"KI-67 antigen expression predicts survival and correlates with histologic subtype in the WHO classification of thymic epithelial tumors","volume":"12","author":"Comin","year":"2004","journal-title":"Int. J. Surg. Pathol."},{"issue":"1","key":"10.1016\/j.critrevonc.2016.01.012_bib0120","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1002\/jso.2930500113","article-title":"Effects of surgical treatment in thymoma with myasthenia gravis: our experience in 103 patients","volume":"50","author":"Crucitti","year":"1992","journal-title":"J. Surg. Oncol."},{"issue":"11","key":"10.1016\/j.critrevonc.2016.01.012_bib0125","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1200\/JCO.1988.6.11.1722","article-title":"Invasive thymoma: the role of mediastinal irradiation following complete or incomplete surgical resection","volume":"6","author":"Curran","year":"1988","journal-title":"J. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.critrevonc.2016.01.012_bib0130","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.ijrobp.2007.10.006","article-title":"Novel prognostic groups in thymic epithelial tumors: assessment of risk and therapeutic strategy selection","volume":"71","author":"D\u2019Angelillo","year":"2008","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"4","key":"10.1016\/j.critrevonc.2016.01.012_bib0135","first-page":"540","article-title":"18F-FDG accumulation with PET for differentiation between benign and malignant lesions in the thorax","volume":"44","author":"Demura","year":"2003","journal-title":"J. Nucl. Med"},{"key":"10.1016\/j.critrevonc.2016.01.012_bib0140","series-title":"Thoracic and Esophageal Surgery","first-page":"1589","article-title":"Thymic tumors: a review of current diagnosis, classification, and treatment","author":"Detterbeck","year":"2008"},{"issue":"Suppl 3 (7)","key":"10.1016\/j.critrevonc.2016.01.012_bib0145","doi-asserted-by":"crossref","first-page":"S1710","DOI":"10.1097\/JTO.0b013e31821e8cff","article-title":"The Masaoks-Koga stage classification for thymic malignancies: clarification and definition of terms","volume":"3","author":"Detterbeck","year":"2011","journal-title":"J. Thorac. Oncol."},{"issue":"Suppl 3 (7)","key":"10.1016\/j.critrevonc.2016.01.012_bib0150","doi-asserted-by":"crossref","first-page":"S1730","DOI":"10.1097\/JTO.0b013e31821ea567","article-title":"Which way up? Policies and procedures for surgeons and pathologists regarding resection specimens of thymic malignancy","volume":"3","author":"Detterbeck","year":"2011","journal-title":"J. Thor. Oncol."},{"issue":"Suppl 3 (7)","key":"10.1016\/j.critrevonc.2016.01.012_bib0155","doi-asserted-by":"crossref","first-page":"S1698","DOI":"10.1097\/JTO.0b013e31821e7b12","article-title":"A review of prognostic factors in thymic malignancies","volume":"3","author":"Detterbeck","year":"2011","journal-title":"J. Thor. Oncol."},{"issue":"Suppl 4 (10)","key":"10.1016\/j.critrevonc.2016.01.012_bib0160","doi-asserted-by":"crossref","first-page":"S318","DOI":"10.1097\/JTO.0b013e3181f20dab","article-title":"Evaluation and treatment of stage I and II thymoma","volume":"4","author":"Detterbeck","year":"2010","journal-title":"J. Thor. Oncol."},{"issue":"1","key":"10.1016\/j.critrevonc.2016.01.012_bib0165","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.lungcan.2010.09.011","article-title":"Promising efficacy of sorafenib in a relapsed thymic carcinoma with C-KIT exon 11 deletion mutation","volume":"71","author":"Di\u015fel","year":"2011","journal-title":"Lung Cancer"},{"issue":"25","key":"10.1016\/j.critrevonc.2016.01.012_bib0170","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1056\/NEJM199406233302507","article-title":"Myasthenia gravis","volume":"330","author":"Drachman","year":"1994","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.critrevonc.2016.01.012_bib0175","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1055\/s-2007-1020055","article-title":"Epithelial thymus tumors\u2014therapy and prognosis","volume":"36","author":"Elert","year":"1988","journal-title":"Thorac. Cardiovasc. Surg."},{"issue":"4","key":"10.1016\/j.critrevonc.2016.01.012_bib0180","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1111\/j.1699-0463.1998.tb01370.x","article-title":"Expression of bcl-2 in fetal thymus, thymomas and thymic carcinomas: Association with p53 expression and review of the literature","volume":"106","author":"Engel","year":"1998","journal-title":"APMIS"},{"issue":"Suppl 4 (10)","key":"10.1016\/j.critrevonc.2016.01.012_bib0185","doi-asserted-by":"crossref","first-page":"S260","DOI":"10.1097\/JTO.0b013e3181f1f62d","article-title":"Epidemiology of thymoma and associated malignancies","volume":"4","author":"Engels","year":"2010","journal-title":"J. Thorac. Oncol."},{"issue":"5","key":"10.1016\/j.critrevonc.2016.01.012_bib0190","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/S1470-2045(07)70141-9","article-title":"Scannia. Response of thymoma to cetuximab","volume":"8","author":"Farina","year":"2007","journal-title":"Lancet Oncol."},{"issue":"1","key":"10.1016\/j.critrevonc.2016.01.012_bib0195","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1210\/endo.140.1.6398","article-title":"In vitro characterization of somatostatin receptors in the human thymus and effects of somatostatin and octreotide on cultured thymic epithelial cells","volume":"140","author":"Ferone","year":"1999","journal-title":"Endocrinology"},{"issue":"1","key":"10.1016\/j.critrevonc.2016.01.012_bib0200","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1093\/annonc\/mdq313","article-title":"Phase I trial of SU14813 in patients with advanced solid malignancies","volume":"22","author":"Fiedler","year":"2011","journal-title":"Ann. Oncol."},{"issue":"2","key":"10.1016\/j.critrevonc.2016.01.012_bib0205","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1093\/ejcts\/ezs663","article-title":"Thymoma and the increased risk of developing extrathymic malignancies: a multicenter study","volume":"44","author":"Filosso","year":"2013","journal-title":"Eur. J. Cardiothorac. Surg."},{"key":"10.1016\/j.critrevonc.2016.01.012_bib0210","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1002\/1097-0142(19910701)68:1<30::AID-CNCR2820680106>3.0.CO;2-4","article-title":"Chemotherapy for invasive thymoma: a 13-year experience","volume":"68","author":"Fornasiero","year":"1991","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.critrevonc.2016.01.012_bib0215","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.ijrobp.2009.02.016","article-title":"Postoperative radiotherapy after surgical resection of thymoma: differing roles in localized and regional disease","volume":"76","author":"Forquer","year":"2010","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.critrevonc.2016.01.012_bib0220","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/1010-7940(91)90210-B","article-title":"Seventeen years of surgical treatment of thymoma: factors influencing survival","volume":"5","author":"Gamondes","year":"1991","journal-title":"Eur. J. Cardiothorac. Surg."},{"issue":"8","key":"10.1016\/j.critrevonc.2016.01.012_bib0225","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1212\/WNL.43.8.1581","article-title":"Titin antibodies in myasthenia gravis: identification of a major immunogenic region of titin","volume":"43","author":"Gautel","year":"1993","journal-title":"Neurology"},{"key":"10.1016\/j.critrevonc.2016.01.012_bib0230","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1200\/JCO.1996.14.3.814","article-title":"Cisplatin and etoposide combination chemotherapy for locally advanced or metastatic thymoma: A phase II study of the European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group","volume":"14","author":"Giaccone","year":"1996","journal-title":"J. Clin. Oncol."},{"issue":"10","key":"10.1016\/j.critrevonc.2016.01.012_bib0235","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1097\/JTO.0b013e3181b6be57","article-title":"Imatinib mesylate in patients with WHO B3 thymomas and thymic carcinomas","volume":"4","author":"Giaccone","year":"2009","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.critrevonc.2016.01.012_bib0240","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1136\/jcp.48.5.447","article-title":"Oncogene proteins and proliferation antigens in thymomas: increased expression of epidermal growth factor receptor and Ki67 antigen","volume":"48","author":"Gilhus","year":"1995","journal-title":"J. Clin. Pathol."},{"issue":"22","key":"10.1016\/j.critrevonc.2016.01.012_bib0245","doi-asserted-by":"crossref","first-page":"6790","DOI":"10.1158\/1078-0432.CCR-09-0644","article-title":"Comprehensive genomic analysis reveals clinically relevant molecular distinctions between thymic carcinomas and thymomas","volume":"15","author":"Girard","year":"2009","journal-title":"Clin. Cancer. Res."},{"issue":"9","key":"10.1016\/j.critrevonc.2016.01.012_bib0250","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1097\/JTO.0b013e3181e392a8","article-title":"Insulin-like growth factor-1 receptor expression in thymic malignancies","volume":"58","author":"Girard","year":"2010","journal-title":"J. Thorac. Oncol."},{"issue":"Suppl 3 (7)","key":"10.1016\/j.critrevonc.2016.01.012_bib0255","doi-asserted-by":"crossref","first-page":"S1743","DOI":"10.1097\/JTO.0b013e31821ea60c","article-title":"Radiation therapy definitions and reporting guidelines for thymic malignancies","volume":"3","author":"Gomez","year":"2011","journal-title":"J. Thorac. Oncol."},{"issue":"3","key":"10.1016\/j.critrevonc.2016.01.012_bib0260","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1097\/00002371-199510000-00005","article-title":"A phase II trial of subcutaneously administered recombinant human interleukin-2 in patients with relapsed\/refractory thymoma","volume":"18","author":"Gordon","year":"1995","journal-title":"J. Immunother. Emphasis Tumor Immunol."},{"issue":"19","key":"10.1016\/j.critrevonc.2016.01.012_bib0265","doi-asserted-by":"crossref","first-page":"5834","DOI":"10.1158\/1078-0432.CCR-07-1118","article-title":"Phase I dose escalation study of the anti insulin-like growth factor-I receptor monoclonal antibody CP-751,871 in patients with refractory solid tumors","volume":"13","author":"Haluska","year":"2007","journal-title":"Clin. Cancer Res."},{"issue":"12","key":"10.1016\/j.critrevonc.2016.01.012_bib0270","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1097\/JTO.0b013e3182745f73","article-title":"Thymoma-a clinico-pathological long-term study with emphasis on histology and adjuvant radiotherapy dose","volume":"7","author":"Harnath","year":"2012","journal-title":"J. Thorac. Oncol."},{"issue":"1","key":"10.1016\/j.critrevonc.2016.01.012_bib0275","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/BF00194697","article-title":"Thymoma: tumour type related to expression of epidermal growth factor (EGF), EGF-receptor, p53, v-erb B and ras p21","volume":"426","author":"Hayashi","year":"1995","journal-title":"Virchows Arch."},{"issue":"4","key":"10.1016\/j.critrevonc.2016.01.012_bib0280","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1007\/s00432-004-0545-z","article-title":"Loehrer PJ Sr Tyrosine kinase receptor expression in thymomas","volume":"130","author":"Henley","year":"2004","journal-title":"J. Cancer Res. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.critrevonc.2016.01.012_bib0285","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s00432-001-0319-9","article-title":"Loehrer PJ Sr Epidermal growth factor receptor expression in invasive thymoma","volume":"128","author":"Henley","year":"2002","journal-title":"J. Cancer Res. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.critrevonc.2016.01.012_bib0290","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/S0165-4608(03)00098-0","article-title":"Deletion (6)(p22p25) is a recurrent anomaly of thymoma: report of a second case and review of the literature","volume":"146","author":"Herens","year":"2003","journal-title":"Cancer Genet. Cytogenet."},{"issue":"9","key":"10.1016\/j.critrevonc.2016.01.012_bib0295","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1200\/JCO.1999.17.9.2737","article-title":"Treatment of invasive thymoma with single-agent ifosfamide","volume":"17","author":"Highley","year":"1999","journal-title":"J. Clin. Oncol."},{"issue":"10","key":"10.1016\/j.critrevonc.2016.01.012_bib0300","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1038\/bjc.1997.561","article-title":"High frequency of p53 protein expression in thymic carcinoma but not in thymoma","volume":"76","author":"Hino","year":"1997","journal-title":"Br. J. Cancer"},{"issue":"5","key":"10.1016\/j.critrevonc.2016.01.012_bib0305","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1002\/(SICI)1097-0215(19971127)73:5<639::AID-IJC5>3.0.CO;2-Y","article-title":"p16INK4, pRB, p53 and cyclin D1 expression and hypermethylation of CDKN2 gene in thymoma and thymic carcinoma","volume":"73","author":"Hirabayashi","year":"1997","journal-title":"Int. J. Cancer"},{"issue":"2","key":"10.1016\/j.critrevonc.2016.01.012_bib0310","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1093\/annonc\/mdu541","article-title":"West Japan Oncology Group. A multicenter phase II study of carboplatin and paclitaxel for advanced thymic carcinoma: WJOG4207L","volume":"26","author":"Hirai","year":"2015","journal-title":"Ann. Oncol."},{"issue":"2","key":"10.1016\/j.critrevonc.2016.01.012_bib0315","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.lungcan.2008.07.015","article-title":"Aberrant methylation of tumour-related genes in thymic epithelial tumours","volume":"64","author":"Hirose","year":"2009","journal-title":"Lung Cancer"},{"issue":"3","key":"10.1016\/j.critrevonc.2016.01.012_bib0320","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/S0360-3016(01)02656-6","article-title":"Postoperative radiotherapy in thymic carcinoma: treatment results and prognostic factors","volume":"52","author":"Hsu","year":"2002","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.critrevonc.2016.01.012_bib0325","unstructured":"Huang, J., Riely, G., 2016. Chemotherapy plus cetuximab followed by surgical resection in patients with locally advanced or recurrent thymoma or thymic carcinoma. ClinicalTrials.gov NCT01025089."},{"issue":"Suppl 3 (7)","key":"10.1016\/j.critrevonc.2016.01.012_bib0330","doi-asserted-by":"crossref","first-page":"S1691","DOI":"10.1097\/JTO.0b013e3182254ac1","article-title":"Standard outcome measures for thymic malignancies","volume":"3","author":"Huang","year":"2011","journal-title":"J Thorac Oncol"},{"issue":"4","key":"10.1016\/j.critrevonc.2016.01.012_bib0335","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1016\/S0002-9440(10)64426-4","article-title":"Chromosome 6 suffers frequent and multiple aberrations in thymoma","volume":"161","author":"Inoue","year":"2002","journal-title":"Am. J. Pathol."},{"issue":"13","key":"10.1016\/j.critrevonc.2016.01.012_bib0340","first-page":"3708","article-title":"Correlating genetic aberrations with World Health Organization-defined histology and stage across the spectrum of thymomas","volume":"63","author":"Inoue","year":"2003","journal-title":"Cancer Res."},{"issue":"3","key":"10.1016\/j.critrevonc.2016.01.012_bib0345","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1002\/cncr.20811","article-title":"Protein expression and gene amplification of epidermal growth factor receptor in thymomas","volume":"103","author":"Ionescu","year":"2005","journal-title":"Cancer"},{"issue":"Suppl","key":"10.1016\/j.critrevonc.2016.01.012_bib0350","first-page":"177s","article-title":"A phase I dose escalation and pharmacokinetic (PK) study of intravenous aflibercept (VEGF trap) plus docetaxel (D) in patients (pts) with advanced solid tumors: Preliminary results","volume":"26","author":"Isambert","year":"2008","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2016.01.012_bib0355","first-page":"176","article-title":"Clinical management of thymomas: the Memorial Sloan-Kettering Cancer Center experience","volume":"vol. 5","author":"Kaiser","year":"1989"},{"issue":"1","key":"10.1016\/j.critrevonc.2016.01.012_bib0360","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.athoracsur.2013.07.121","article-title":"What is the prevalence of a non-therapeutic thymectomy?","volume":"97","author":"Kent","year":"2014","journal-title":"Ann. Thorac. Surg."},{"issue":"1","key":"10.1016\/j.critrevonc.2016.01.012_bib0365","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1378\/chest.08-2482","article-title":"Apoptosis-related (survivin, Bcl-2), tumor suppressor gene (p53), proliferation (Ki-67), and non receptor tyrosine kinase (Src) markers expression and correlation with clinicopathologic variables in 60 thymic neoplasms","volume":"136","author":"Khoury","year":"2009","journal-title":"Chest"},{"issue":"3","key":"10.1016\/j.critrevonc.2016.01.012_bib0370","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.lungcan.2003.12.010","article-title":"Phase II study of a multidisciplinary approach with induction chemotherapy, followed by surgical resection, radiation therapy, and consolidation chemotherapy for unresectable malignant thymomas: final report","volume":"44","author":"Kim","year":"2004","journal-title":"Lung Cancer"},{"issue":"4","key":"10.1016\/j.critrevonc.2016.01.012_bib0375","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.ejcts.2005.06.034","article-title":"Expression of neurotrophin receptors in surgically resected thymic epithelial tumors","volume":"28","author":"Kim","year":"2005","journal-title":"Eur. J. Cardiothorac. Surg."},{"issue":"3","key":"10.1016\/j.critrevonc.2016.01.012_bib0380","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1378\/chest.127.3.755","article-title":"Prognostic and clinical relevance of the World Health Organization schema for the classification of the thymic epithelial tumors: a clinicopathologic study of 108 patients and literature review","volume":"127","author":"Kim","year":"2005","journal-title":"Chest"},{"issue":"6","key":"10.1016\/j.critrevonc.2016.01.012_bib0385","first-page":"1525","article-title":"A single institutional experience of surgically resected thymic epithelial tumors over 10 years: clinical outcomes and clinicopathologic features","volume":"19","author":"Kim","year":"2008","journal-title":"Oncol. Rep."},{"issue":"5","key":"10.1016\/j.critrevonc.2016.01.012_bib0390","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/j.1440-1827.1994.tb02936.x","article-title":"A review of 79 thymomas: modification of staging and reapprisal of conventional division into invasive and non-invasive thymoma","volume":"44","author":"Koga","year":"1994","journal-title":"Pathol. Int."},{"key":"10.1016\/j.critrevonc.2016.01.012_bib0395","doi-asserted-by":"crossref","first-page":"330","DOI":"10.3389\/fonc.2013.00330","article-title":"Radiotherapy for thymic carcinoma: adjuvant, inductive, and definitive","volume":"3","author":"Komaki","year":"2014","journal-title":"Front. Oncol."},{"issue":"6","key":"10.1016\/j.critrevonc.2016.01.012_bib0400","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1016\/S0003-4975(03)01017-8","article-title":"Lymphogenous and hematogenous metastasis of thymic epithelial tumors","volume":"76","author":"Kondo","year":"2003","journal-title":"Ann. Thorac. Surg."},{"issue":"3","key":"10.1016\/j.critrevonc.2016.01.012_bib0405","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/S0003-4975(03)00555-1","article-title":"Therapy for thymic epithelial tumors: a clinical study of 1,320 atients from Japan","volume":"76","author":"Kondo","year":"2003","journal-title":"Ann. Thorac. Surg."},{"issue":"4","key":"10.1016\/j.critrevonc.2016.01.012_bib0410","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/j.athoracsur.2003.07.042","article-title":"WHO histological classification is a prognostic indicator in thymoma","volume":"77","author":"Kondo","year":"2004","journal-title":"Ann. Thorac. Surg."},{"issue":"5","key":"10.1016\/j.critrevonc.2016.01.012_bib0415","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1016\/j.athoracsur.2008.11.022","article-title":"Adjuvant radiotherapy for thymic epithelial tumors: a systematic review and meta-analysis","volume":"87","author":"Korst","year":"2009","journal-title":"Ann. Thorac. Surg."},{"issue":"1","key":"10.1016\/j.critrevonc.2016.01.012_bib0420","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.jtcvs.2013.08.061","article-title":"Neoadjuvant chemoradiotherapy for locally advanced thymic tumors: a phase II, multi-institutional clinical trial","volume":"147","author":"Korst","year":"2014","journal-title":"J. Thorac. Cardiovasc. Surg."},{"issue":"7","key":"10.1016\/j.critrevonc.2016.01.012_bib0425","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1038\/bjc.1996.157","article-title":"PET imaging of primary mediastinal tumours","volume":"73","author":"Kubota","year":"1996","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.critrevonc.2016.01.012_bib0430","series-title":"World Health Organization Classification of Tumors: Pathology and Genetics of Tumors of the Lung, Pleura, Thymus and Heart","first-page":"146","article-title":"Tumours of the thymus","author":"Kuo","year":"2004"},{"issue":"Suppl 16","key":"10.1016\/j.critrevonc.2016.01.012_bib0435","doi-asserted-by":"crossref","first-page":"7068","DOI":"10.1200\/jco.2005.23.16_suppl.7068","article-title":"Phase II study of gefitinib treatment in advanced thymic malignancies","volume":"23","author":"Kurup","year":"2005","journal-title":"J. Clin. Oncol."},{"issue":"4","key":"10.1016\/j.critrevonc.2016.01.012_bib0440","first-page":"634","article-title":"In vivo detection of malignant thymic masses by indium-111-DTPA-D-Phe1-octreotide scintigraphy","volume":"39","author":"Lastoria","year":"1998","journal-title":"J. Nucl. Med."},{"issue":"15","key":"10.1016\/j.critrevonc.2016.01.012_bib0445","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1200\/JCO.2010.32.9607","article-title":"Phase II study of carboplatin and paclitaxel in advanced thymoma and thymic carcinoma","volume":"29","author":"Lemma","year":"2011","journal-title":"J. Clin. Oncol."},{"issue":"6","key":"10.1016\/j.critrevonc.2016.01.012_bib0450","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1016\/j.athoracsur.2010.02.043","article-title":"Anterior diaphragmatic plication in mediastinal surgery: the reefing the mainsail technique","volume":"90","author":"Leo","year":"2010","journal-title":"Ann. Thorac. Surg."},{"issue":"5","key":"10.1016\/j.critrevonc.2016.01.012_bib0455","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/S0046-8177(78)80131-2","article-title":"Thymic hyperplasia and neoplasia. A review of current concepts","volume":"9","author":"Levine","year":"1978","journal-title":"Hum. Pathol."},{"issue":"11","key":"10.1016\/j.critrevonc.2016.01.012_bib0460","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.1002\/1097-0142(19871201)60:11<2727::AID-CNCR2820601125>3.0.CO;2-D","article-title":"Thymoma A clinicopathologic review","volume":"60","author":"Lewis","year":"1987","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.critrevonc.2016.01.012_bib0465","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s12032-008-9100-0","article-title":"Response to sorafenib in cisplatin resistant thymic carcinoma: a case report","volume":"26","author":"Li","year":"2009","journal-title":"Med. Oncol."},{"issue":"3","key":"10.1016\/j.critrevonc.2016.01.012_bib0470","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1002\/cncr.22404","article-title":"Topoisomerase 2alpha plays a pivotal role in the tumor biology of stage IV thymic neoplasia","volume":"109","author":"Liu","year":"2007","journal-title":"Cancer"},{"issue":"6","key":"10.1016\/j.critrevonc.2016.01.012_bib0475","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1200\/JCO.1994.12.6.1164","article-title":"Cisplatin plus doxorubicin plus cyclophosphamide in metastatic or recurrent thymoma: final results of an intergroup trial\u2014The Eastern Cooperative Oncology Group, Southwest Oncology Group, and Southeastern Cancer Study Group","volume":"12","author":"Loehrer","year":"1994","journal-title":"J. Clin. Oncol."},{"issue":"9","key":"10.1016\/j.critrevonc.2016.01.012_bib0480","doi-asserted-by":"crossref","first-page":"3093","DOI":"10.1200\/JCO.1997.15.9.3093","article-title":"Cisplatin, doxorubicin, and cyclophosphamide plus thoracic radiation therapy for limited-stage unresectable thymoma. An intergroup trial","volume":"15","author":"Loehrer","year":"1997","journal-title":"J. Clin. Oncol."},{"issue":"11","key":"10.1016\/j.critrevonc.2016.01.012_bib0485","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1002\/1097-0142(20010601)91:11<2010::AID-CNCR1226>3.0.CO;2-2","article-title":"Combined etoposide, ifosfamide, and cisplatin in the treatment of patients with advanced thymoma and thymic carcinoma: an intergroup trial","volume":"91","author":"Loehrer","year":"2001","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.critrevonc.2016.01.012_bib0490","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1200\/JCO.2004.02.047","article-title":"Eastern Cooperative Oncology Group Phase II Trial. Octreotide alone or with prednisone in patients with advanced thymoma and thymic carcinoma: an Eastern Cooperative Oncology Group Phase II Trial","volume":"22","author":"Loehrer","year":"2004","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.critrevonc.2016.01.012_bib0495","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1200\/JCO.2004.02.047","article-title":"Eastern Cooperative Oncology Group Phase II Trial. Octreotide alone or with prednisone in patients with advanced thymoma and thymic carcinoma: an Eastern Cooperative Oncology Group Phase II trial","volume":"22","author":"Loehrer","year":"2004","journal-title":"J. Clin. Oncol."},{"issue":"Suppl","key":"10.1016\/j.critrevonc.2016.01.012_bib0500","article-title":"A phase II trial of pemetrexed in patients with recurrent thymoma or thymic carcinoma","volume":"24","author":"Loehrer","year":"2006","journal-title":"J. Clin. Oncol."},{"issue":"Suppl 4 (10)","key":"10.1016\/j.critrevonc.2016.01.012_bib0505","doi-asserted-by":"crossref","first-page":"S348","DOI":"10.1097\/JTO.0b013e3181f20f27","article-title":"Surgical treatment of recurrent thymomas","volume":"4","author":"Lucchi","year":"2010","journal-title":"J. Thor. Oncol."},{"issue":"5","key":"10.1016\/j.critrevonc.2016.01.012_bib0510","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1016\/j.jtcvs.2008.09.033","article-title":"Management of pleural recurrence after curative resection of thymoma","volume":"137","author":"Lucchi","year":"2009","journal-title":"J. Thorac. Cardiovasc. Surg."},{"issue":"4","key":"10.1016\/j.critrevonc.2016.01.012_bib0515","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1002\/1097-0142(19910815)68:4<706::AID-CNCR2820680407>3.0.CO;2-H","article-title":"Neoadjuvant chemotherapy, surgery, and postoperative radiation therapy for invasive thymoma","volume":"68","author":"Macchiarini","year":"1991","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.critrevonc.2016.01.012_bib0520","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/0003-4975(91)90478-9","article-title":"Thymoma: results of 241 operated cases","volume":"51","author":"Maggi","year":"1991","journal-title":"Ann. Thorac. Surg."},{"issue":"Suppl 3 (7)","key":"10.1016\/j.critrevonc.2016.01.012_bib0525","doi-asserted-by":"crossref","first-page":"S1724","DOI":"10.1097\/JTO.0b013e31821ea57c","article-title":"Policies and reporting guidelines for small biopsy specimens of mediastinal masses","volume":"3","author":"Marchevsky","year":"2011","journal-title":"J. Thor. Oncol."},{"issue":"2","key":"10.1016\/j.critrevonc.2016.01.012_bib0530","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/BF00737071","article-title":"Thymoma and thymic carcinoma. Relation of thymoma epithelial cells to the cortical and medullary differentiation of the thymus","volume":"407","author":"Marino","year":"1985","journal-title":"Virchows Arch. Pathol. Anat. Histopathol."},{"issue":"Suppl 4","key":"10.1016\/j.critrevonc.2016.01.012_bib0535","doi-asserted-by":"crossref","first-page":"S296","DOI":"10.1097\/JTO.0b013e3181f209ca","article-title":"Imaging thymoma","volume":"4","author":"Marom","year":"2010","journal-title":"J. Thorac. Oncol."},{"issue":"5","key":"10.1016\/j.critrevonc.2016.01.012_bib0540","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1016\/j.jtcvs.2012.07.082","article-title":"Robot-aided thoracoscopy thymectomy for early-stage thymoma: a multicenter european study","volume":"144","author":"Marulli","year":"2012","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"10.1016\/j.critrevonc.2016.01.012_bib0545","first-page":"152","article-title":"Thymomas","volume":"vol. 7","author":"Marx","year":"2004"},{"issue":"4","key":"10.1016\/j.critrevonc.2016.01.012_bib0550","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/S0022-5223(19)40309-7","article-title":"Distribution of thymic tissue at the anterior mediastinum","volume":"70","author":"Masaoka","year":"1975","journal-title":"J. Thorac. Cardiovasc. Surg."},{"issue":"11","key":"10.1016\/j.critrevonc.2016.01.012_bib0555","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1002\/1097-0142(19811201)48:11<2485::AID-CNCR2820481123>3.0.CO;2-R","article-title":"Follow-up study of thymomas with special reference to their clinical stages","volume":"48","author":"Masaoka","year":"1981","journal-title":"Cancer"},{"issue":"5","key":"10.1016\/j.critrevonc.2016.01.012_bib0560","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/1010-7940(94)90155-4","article-title":"Thymectomy and malignancy","volume":"8","author":"Masaoka","year":"1994","journal-title":"Eur. J. Cardiothorac. Surg."},{"issue":"1","key":"10.1016\/j.critrevonc.2016.01.012_bib0565","first-page":"25","article-title":"Surgical treatment of thymoma","volume":"45","author":"Mehran","year":"2002","journal-title":"Can. J. Surg."},{"issue":"1","key":"10.1016\/j.critrevonc.2016.01.012_bib0570","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.canlet.2006.07.003","article-title":"Mutational status of the epidermal growth factor receptor (EGFR) gene in thymomas and thymic carcinomas","volume":"248","author":"Meister","year":"2007","journal-title":"Cancer Lett."},{"issue":"10","key":"10.1016\/j.critrevonc.2016.01.012_bib0575","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1002\/cncr.21433","article-title":"Long term disease-free survival of patients with radically resected thymomas: Relevance of cell-cycle protein expression","volume":"104","author":"Mineo","year":"2005","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.critrevonc.2016.01.012_bib0580","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0003-4975(10)62558-1","article-title":"Recurrence of thymoma: clinicopathological features, therapy and prognosis","volume":"39","author":"Monden","year":"1985","journal-title":"Ann. Thorac. Surg."},{"issue":"1","key":"10.1016\/j.critrevonc.2016.01.012_bib0585","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0003-4975(01)02633-9","article-title":"Thymoma: trends over time","volume":"72","author":"Moore","year":"2001","journal-title":"Ann. Thorac. Surg."},{"issue":"4\u20136","key":"10.1016\/j.critrevonc.2016.01.012_bib0590","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1007\/s11864-009-0084-6","article-title":"The World Health Organization (WHO) histologic classification of thymomas: a reanalysis","volume":"9","author":"Moran","year":"2008","journal-title":"Curr. Treat. Options Oncol."},{"issue":"3","key":"10.1016\/j.critrevonc.2016.01.012_bib0595","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.hoc.2008.03.002","article-title":"Thymic carcinoma: current concepts and histologic features","volume":"22","author":"Moran","year":"2008","journal-title":"Hematol. Oncol. Clin. N. Am."},{"issue":"3","key":"10.1016\/j.critrevonc.2016.01.012_bib0600","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1309\/AJCP76KEGWQKWOKA","article-title":"Thymomas I: a clinicopathologic correlation of 250 cases with emphasis on the World Health Organization schema","volume":"137","author":"Moran","year":"2012","journal-title":"Am. J. Clin. Pathol."},{"issue":"6","key":"10.1016\/j.critrevonc.2016.01.012_bib0605","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1136\/thx.48.6.632","article-title":"Percutaneous needle biopsy of the mediastinum: review of 94 procedures","volume":"48","author":"Morrissey","year":"1993","journal-title":"Thorax"},{"issue":"2","key":"10.1016\/j.critrevonc.2016.01.012_bib0610","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/BF03218097","article-title":"Results from surgical treatment for thymoma. 43 years of experience","volume":"48","author":"Murakawa","year":"2000","journal-title":"Jpn. J. Thorac. Cardiovasc. Surg."},{"issue":"4","key":"10.1016\/j.critrevonc.2016.01.012_bib0615","doi-asserted-by":"crossref","first-page":"e43","DOI":"10.1093\/ejcts\/ezr322","article-title":"Robotic extended thymectomy for early stage thymomas","volume":"41","author":"Mussi","year":"2012","journal-title":"Eur. J. Cardiothor. Surg."},{"issue":"4","key":"10.1016\/j.critrevonc.2016.01.012_bib0620","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/S0360-3016(99)00514-3","article-title":"Stage III thymoma. Pattern of failure after surgery and postoperative radiotherapy and its implication for future study","volume":"46","author":"Myojin","year":"2000","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"1","key":"10.1016\/j.critrevonc.2016.01.012_bib0625","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1378\/chest.128.1.140","article-title":"Immunohistochemical KIT (CD117) expression in thymic epithelial tumors","volume":"128","author":"Nakagawa","year":"2005","journal-title":"Chest"},{"issue":"6","key":"10.1016\/j.critrevonc.2016.01.012_bib0630","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/S0022-5223(19)35673-9","article-title":"Thymoma: results with complete resection and adjuvant postoperative irradiation in 141 consecutive patients","volume":"95","author":"Nakahara","year":"1988","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"10.1016\/j.critrevonc.2016.01.012_bib0635","unstructured":"National Cancer Institute, 2016. A Phase 1\/2 Study of PXD101 (Belinostat) in combination with Cisplatin, Doxorubicin and Cyclophosphamide in the first line treatment of advanced or recurrent thymic malignancies. ClinicalTrials.gov NCT01100944."},{"issue":"2","key":"10.1016\/j.critrevonc.2016.01.012_bib0640","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/1097-0142(19810715)48:2<223::AID-CNCR2820480202>3.0.CO;2-0","article-title":"Malignant thymoma: renal metastases responding to cis-platinum","volume":"48","author":"Needles","year":"1981","journal-title":"Cancer"},{"key":"10.1016\/j.critrevonc.2016.01.012_bib0645","unstructured":"Nerviano Medical Sciences. Phase II Study of oral PHA-848125AC in patients with thymic carcinoma. ClinicalTrials.gov NCT01011439."},{"key":"10.1016\/j.critrevonc.2016.01.012_bib0650","unstructured":"Nerviano Medical Sciences. Study of oral PHA-848125AC in patients with malignant thymoma previously treated with multiple lines of chemotherapy. ClinicalTrials.gov NCT01301391."},{"issue":"5","key":"10.1016\/j.critrevonc.2016.01.012_bib0655","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1002\/cncr.10373","article-title":"Postoperative radiotherapy for patients with completely resected thymoma: a multi-institutional, retrospective review of 103 cases","volume":"94","author":"Ogawa","year":"2002","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.critrevonc.2016.01.012_bib0660","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S0022-5223(99)70343-0","article-title":"Results of surgical treatment of thymomas with special reference to the involved organs","volume":"117","author":"Okumura","year":"1999","journal-title":"J. Thorac. Cardiovasc. Surg."},{"issue":"4","key":"10.1016\/j.critrevonc.2016.01.012_bib0665","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s11748-007-0185-8","article-title":"Immunological function of thymoma and pathogenesis of paraneoplastic myasthenia gravis","volume":"56","author":"Okumura","year":"2008","journal-title":"Gen. Thorac. Cardiovasc. Surg."},{"issue":"5","key":"10.1016\/j.critrevonc.2016.01.012_bib0670","first-page":"823","article-title":"p53 alteration, proliferating cell nuclear antigen, and nucleolar organizer regions in thymic epithelial tumors","volume":"1","author":"Oyama","year":"1998","journal-title":"Int. J. Mol. Med."},{"issue":"4","key":"10.1016\/j.critrevonc.2016.01.012_bib0675","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1056\/NEJM199701233360405","article-title":"Successful treatment of a patient with a thymoma and pure red-cell aplasia with octreotide and prednisone","volume":"336","author":"Palmieri","year":"1997","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.critrevonc.2016.01.012_bib0680","doi-asserted-by":"crossref","first-page":"757","DOI":"10.2741\/2098","article-title":"Cetuximab is an active treatment of metastatic and chemorefractory thymoma","volume":"12","author":"Palmieri","year":"2007","journal-title":"Front. Biosci."},{"issue":"6","key":"10.1016\/j.critrevonc.2016.01.012_bib0685","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1093\/annonc\/mdp483","article-title":"Preliminary results of phase II study of capecitabine and gemcitabine (CAP-GEM) in patients with metastatic pretreated thymic epithelial tumors (TETs)","volume":"21","author":"Palmieri","year":"2010","journal-title":"Ann. Oncol."},{"issue":"suppl","key":"10.1016\/j.critrevonc.2016.01.012_bib0690","article-title":"Somatostatin analogs as mainteinance therapy in heavily pretreated thymic epithelial tumors","volume":"33","author":"Palmieri","year":"2015","journal-title":"J. Clin. Oncol."},{"issue":"9","key":"10.1016\/j.critrevonc.2016.01.012_bib0695","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/0046-8177(94)90008-6","article-title":"The clinicopathological correlation of epithelial subtyping in thymoma: a study of 112 consecutive cases","volume":"25","author":"Pan","year":"1994","journal-title":"Hum. Pathol."},{"issue":"9","key":"10.1016\/j.critrevonc.2016.01.012_bib0700","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.1002\/1097-0142(20011101)92:9<2406::AID-CNCR1589>3.0.CO;2-7","article-title":"Thymoma is associated with an increased risk of second malignancy","volume":"92","author":"Pan","year":"2001","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.critrevonc.2016.01.012_bib0705","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1046\/j.1365-2559.2003.01663.x","article-title":"Expression of apoptosis-related markers and HER-2\/neu in thymic epithelial tumours","volume":"43","author":"Pan","year":"2003","journal-title":"Histopathology"},{"issue":"11","key":"10.1016\/j.critrevonc.2016.01.012_bib0710","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1053\/j.humpath.2003.07.002","article-title":"Expression of calretinin and other mesothelioma-related markers in thymic carcinoma and thymoma","volume":"34","author":"Pan","year":"2003","journal-title":"Hum. Pathol."},{"issue":"3","key":"10.1016\/j.critrevonc.2016.01.012_bib0715","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1002\/path.1514","article-title":"KIT (CD117) is frequently overexpressed in thymic carcinomas but is absent in thymomas","volume":"202","author":"Pan","year":"2004","journal-title":"J. Pathol."},{"issue":"5","key":"10.1016\/j.critrevonc.2016.01.012_bib0720","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1016\/j.ijrobp.2011.03.010","article-title":"Evaluation of the role of radiation therapy in the management of malignant thymoma","volume":"82","author":"Patel","year":"2012","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"1","key":"10.1016\/j.critrevonc.2016.01.012_bib0725","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1510\/icvts.2010.253997","article-title":"Synchronous B3 thymoma and lung bronchoalveolar carcinoma","volume":"12","author":"Patella","year":"2011","journal-title":"Interact. Cardiovasc. Thorac. Surg."},{"issue":"2","key":"10.1016\/j.critrevonc.2016.01.012_bib0730","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1093\/ajcp\/93.2.190","article-title":"The prognostic implication of thymoma histologic subtyping. A study of 80 consecutive cases","volume":"93","author":"Pescarmona","year":"1990","journal-title":"Am. J. Clin. Pathol."},{"issue":"1","key":"10.1016\/j.critrevonc.2016.01.012_bib0735","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1365-2559.1993.tb01181.x","article-title":"Expression of epidermal and nerve growth factor receptors in human thymus and thymomas","volume":"23","author":"Pescarmona","year":"1993","journal-title":"Histopathology"},{"issue":"3","key":"10.1016\/j.critrevonc.2016.01.012_bib0740","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1002\/(SICI)1097-0215(19960621)69:3<180::AID-IJC5>3.0.CO;2-W","article-title":"p53 expression and proliferative activity predict survival in non-invasive thymomas","volume":"69","author":"Pich","year":"1996","journal-title":"Int. J. Cancer"},{"issue":"2","key":"10.1016\/j.critrevonc.2016.01.012_bib0745","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1046\/j.1365-2559.2002.01328.x","article-title":"Immunohistochemical markers in the differentiation of thymic and pulmonary neoplasms","volume":"40","author":"Pomplun","year":"2002","journal-title":"Histopathology"},{"key":"10.1016\/j.critrevonc.2016.01.012_bib0750","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1002\/1097-0142(19940715)74:2<606::AID-CNCR2820740212>3.0.CO;2-T","article-title":"Thymoma: histologic subclassification is an independent prognostic factor","volume":"74","author":"Quintanilla-Martinez","year":"1994","journal-title":"Cancer"},{"key":"10.1016\/j.critrevonc.2016.01.012_bib0755","unstructured":"RARECAREnet\u2014Information Network on Rare Cancers. Available at: ."},{"issue":"Suppl","key":"10.1016\/j.critrevonc.2016.01.012_bib0760","doi-asserted-by":"crossref","first-page":"e17525","DOI":"10.1200\/jco.2010.28.15_suppl.e17525","article-title":"Phase II study of the insulin-like growth factor-1 receptor (IGF-1R) antibody cixutumumab (C) in patients (pts) with thymoma (T) and thymic carcinoma (TC)","volume":"28","author":"Rajan","year":"2010","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2016.01.012_bib0765","unstructured":"Rajan, A. Multicenter Phase II Study of IMC-A12 in patients with thymoma and thymic carcinoma who have been previously treated with chemotherapy. ClinicalTrials.gov NCT00965250."},{"issue":"2","key":"10.1016\/j.critrevonc.2016.01.012_bib0770","first-page":"173","article-title":"Thymic neoplasm: a rare disease with a complex clinical presentation","volume":"5","author":"Rashid","year":"2013","journal-title":"J. Thorac. Dis."},{"issue":"2","key":"10.1016\/j.critrevonc.2016.01.012_bib0775","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/S0022-5223(96)70265-9","article-title":"Prognostic factors and long-term results after thymoma resection: a series of 307 patients","volume":"112","author":"Regnard","year":"1996","journal-title":"J. Thorac. Cardiovasc. Surg."},{"issue":"6","key":"10.1016\/j.critrevonc.2016.01.012_bib0780","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1016\/S0003-4975(97)01175-2","article-title":"Results of re-resection for recurrent thymomas","volume":"64","author":"Regnard","year":"1997","journal-title":"Ann. Thorac. Surg."},{"issue":"1","key":"10.1016\/j.critrevonc.2016.01.012_bib0785","first-page":"79","article-title":"Successful resection of a thymoma in an elderly patient","volume":"18","author":"Rendina","year":"1988","journal-title":"Ital. J. Surg. Sci."},{"key":"10.1016\/j.critrevonc.2016.01.012_bib0790","series-title":"Atlas of Tumor Pathology. Fascile 13, Series 2","article-title":"Tumors of the thymus","author":"Rosai","year":"1976"},{"key":"10.1016\/j.critrevonc.2016.01.012_bib0795","series-title":"WHO International Classification of Tumors","article-title":"Histological typing of tumors of the thymus","author":"Rosai","year":"1999"},{"issue":"4","key":"10.1016\/j.critrevonc.2016.01.012_bib0800","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1001\/archinte.1984.00350160117020","article-title":"Disorders of the thymus","volume":"144","author":"Rosenow","year":"1984","journal-title":"Arch. Intern. Med."},{"issue":"1","key":"10.1016\/j.critrevonc.2016.01.012_bib0805","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0022-5223(97)70399-4","article-title":"Recurrence of thymoma: analysis of clinicopathological features, treatment and outcome","volume":"113","author":"Ruffini","year":"1997","journal-title":"J. Thorac. Cardiovasc. Surg."},{"issue":"3","key":"10.1016\/j.critrevonc.2016.01.012_bib0810","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1097\/JTO.0b013e318207cd74","article-title":"European Society of Thoracic Surgeons Thymic Questionnaire Working Group. Management of thymic tumors: a survey of current practice among members of the European Society of Thoracic Surgeons","volume":"6","author":"Ruffini","year":"2011","journal-title":"J. Thor. Oncol."},{"issue":"Suppl 15","key":"10.1016\/j.critrevonc.2016.01.012_bib0815","first-page":"452s","article-title":"Imatinib for the treatment of thymic carcinoma","volume":"26","author":"Salter","year":"2008","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.critrevonc.2016.01.012_bib0820","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/1097-0142(197601)37:1<229::AID-CNCR2820370133>3.0.CO;2-2","article-title":"Thymoma: a clinical and pathological study of 65 cases","volume":"37","author":"Salyer","year":"1976","journal-title":"Cancer"},{"issue":"11","key":"10.1016\/j.critrevonc.2016.01.012_bib0825","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1007\/s005950170021","article-title":"Elevated serum vascular endothelial growth factor and basic fibroblast growth factor levels in patients with thymic epithelial neoplasms","volume":"31","author":"Sasaki","year":"2001","journal-title":"Surg. Today"},{"issue":"2","key":"10.1016\/j.critrevonc.2016.01.012_bib0830","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s005950300018","article-title":"Thymidylate synthase and dihydropyrimidine dehydrogenase mRNA levels in thymoma","volume":"33","author":"Sasaki","year":"2003","journal-title":"Surg. Today"},{"key":"10.1016\/j.critrevonc.2016.01.012_bib0835","unstructured":"Schalke, B. Efficacy of medical treatment with SOM230 LAR in patients with primary inoperable thymoma and\/or with local recurrent thymoma to reduce tumor size. ClinicalTrials.gov NCT02021942."},{"issue":"7","key":"10.1016\/j.critrevonc.2016.01.012_bib0840","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/j.ejca.2012.02.047","article-title":"RARECARE Working Group. Rare thoracic cancers: including peritoneum mesothelioma","volume":"48","author":"Siesling","year":"2012","journal-title":"Eur. J. Cancer"},{"issue":"2","key":"10.1016\/j.critrevonc.2016.01.012_bib0845","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1001\/archinte.1974.00320200184029","article-title":"The spectrum of diseases associated with thymoma","volume":"134","author":"Souadjian","year":"1974","journal-title":"Arch. Intern. Med."},{"issue":"3","key":"10.1016\/j.critrevonc.2016.01.012_bib0850","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1158\/1078-0432.CCR-07-1786","article-title":"A phase 1 pharmacokinetic and pharmacodynamic study of the histone deacetylase inhibitor belinostat in patients with advanced solid tumors","volume":"14","author":"Steele","year":"2008","journal-title":"Clin. Cancer Res."},{"issue":"6","key":"10.1016\/j.critrevonc.2016.01.012_bib0855","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1046\/j.1365-2559.1997.5730805.x","article-title":"Expression of p53, mdm2, p21\/waf1 and bcl-2 proteins in thymomas","volume":"30","author":"Stefanaki","year":"1997","journal-title":"Histopathology"},{"issue":"25","key":"10.1016\/j.critrevonc.2016.01.012_bib0860","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.1056\/NEJM200406173502523","article-title":"Thymic carcinoma with overexpression of mutated KIT and the response to imatinib","volume":"350","author":"Str\u00f6bel","year":"2004","journal-title":"N. Engl. J. Med."},{"issue":"8","key":"10.1016\/j.critrevonc.2016.01.012_bib0865","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1200\/JCO.2004.10.113","article-title":"Tumor recurrence and survival in patients treated for thymomas and thymic squamous cell carcinomas: a retrospective analysis","volume":"22","author":"Str\u00f6bel","year":"2004","journal-title":"J. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.critrevonc.2016.01.012_bib0870","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1038\/sj.bjc.6605740","article-title":"Sunitinib in metastatic thymic carcinomas: laboratory findings and initial clinical experience","volume":"103","author":"Str\u00f6bel","year":"2010","journal-title":"Br. J. Cancer"},{"issue":"10","key":"10.1016\/j.critrevonc.2016.01.012_bib0875","first-page":"1628","article-title":"18F-FDG PET\/CT of thymic epithelial tumors: usefulness for distinguishing and staging tumor subgroups","volume":"47","author":"Sung","year":"2006","journal-title":"J. Nucl. Med."},{"issue":"4","key":"10.1016\/j.critrevonc.2016.01.012_bib0880","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1002\/1097-0142(19910215)67:4<1025::AID-CNCR2820670427>3.0.CO;2-F","article-title":"Thymic carcinoma: a clinicopathologic study of 60 cases","volume":"67","author":"Suster","year":"1991","journal-title":"Cancer"},{"issue":"6","key":"10.1016\/j.critrevonc.2016.01.012_bib0885","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1093\/jjco\/hyl028","article-title":"Expression and mutation statuses of epidermal growth factor receptor in thymic epithelial tumors","volume":"36","author":"Suzuki","year":"2006","journal-title":"Jpn. J. Clin. Oncol."},{"issue":"4","key":"10.1016\/j.critrevonc.2016.01.012_bib0890","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1093\/ajcp\/104.4.375","article-title":"p53 protein expression and p53 gene mutation in thymic epithelial tumors: an immunohistochemical and DNA sequencing study","volume":"104","author":"Tateyama","year":"1995","journal-title":"Am. J. Clin. Pathol."},{"issue":"2","key":"10.1016\/j.critrevonc.2016.01.012_bib0895","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S1470-2045(14)71181-7","article-title":"Sunitinib in patients with chemotherapy-refractory thymoma and thymic carcinoma: an open-label phase 2 trial","volume":"16","author":"Thomas","year":"2015","journal-title":"Lancet Oncol."},{"issue":"Suppl 3 (7)","key":"10.1016\/j.critrevonc.2016.01.012_bib0900","doi-asserted-by":"crossref","first-page":"S1739","DOI":"10.1097\/JTO.0b013e31821ea553","article-title":"Standard terms, definitions and policies for minimally invasive resection of thymoma","volume":"3","author":"Toker","year":"2011","journal-title":"J Thor Oncol"},{"key":"10.1016\/j.critrevonc.2016.01.012_bib0905","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1067\/mtc.2002.124389","article-title":"Correlation between tumor angiogenesis and invasiveness in thymic epithelial tumors","volume":"124","author":"Tomita","year":"2002","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"10.1016\/j.critrevonc.2016.01.012_bib0910","series-title":"Harris CC for International Academy of Pathology (IAP). TNM Classification of Malignant Thymic Epithelial Tumours. Pathology and Genetics of Tumours of the Lung, Pleura, Thymus and Heart","first-page":"147","author":"Travis","year":"2004"},{"issue":"3","key":"10.1016\/j.critrevonc.2016.01.012_bib0915","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.lungcan.2008.03.035","article-title":"Absence of gene mutations in KIT-positive thymic epithelial tumors","volume":"62","author":"Tsuchida","year":"2008","journal-title":"Lung Cancer"},{"issue":"7","key":"10.1016\/j.critrevonc.2016.01.012_bib0920","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1038\/labinvest.3700292","article-title":"Malignant transformation of thymoma in recipient rats by heterotopic thymus transplantation from HTLV-I transgenic rats","volume":"85","author":"Tsuji","year":"2005","journal-title":"Lab. Invest."},{"issue":"3","key":"10.1016\/j.critrevonc.2016.01.012_bib0925","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/0167-8140(90)90154-O","article-title":"Role of radiation therapy in locally advanced thymoma","volume":"19","author":"Urgesi","year":"1990","journal-title":"Radiother. Oncol."},{"issue":"23","key":"10.1016\/j.critrevonc.2016.01.012_bib0930","doi-asserted-by":"crossref","first-page":"5413","DOI":"10.1002\/cncr.24618","article-title":"Postoperative radiation therapy after complete resection of thymoma has little impact on survival","volume":"115","author":"Utsumi","year":"2009","journal-title":"Cancer"},{"issue":"5","key":"10.1016\/j.critrevonc.2016.01.012_bib0935","first-page":"843","article-title":"The role of postoperative radiotherapy in the management of patients with thymic tumors. A retrospective study","volume":"23","author":"Vassiliou","year":"2009","journal-title":"In Vivo"},{"issue":"6","key":"10.1016\/j.critrevonc.2016.01.012_bib0940","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1016\/S0003-4975(97)00629-2","article-title":"Multimodality treatment of thymoma: a prospective study","volume":"64","author":"Venuta","year":"1997","journal-title":"Ann. Thorac. Surg."},{"issue":"6","key":"10.1016\/j.critrevonc.2016.01.012_bib0945","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1016\/S0003-4975(03)01020-8","article-title":"Long-term outcome after multimodality treatment for stage III thymic tumors","volume":"76","author":"Venuta","year":"2003","journal-title":"Ann. Thorac. Surg."},{"issue":"5","key":"10.1016\/j.critrevonc.2016.01.012_bib0950","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1002\/1097-0142(19850301)55:5<1074::AID-CNCR2820550524>3.0.CO;2-T","article-title":"Thymoma: a comparative study of clinical stages, histologic features, and survival in 200 cases","volume":"55","author":"Verley","year":"1985","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.critrevonc.2016.01.012_bib0955","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/bjc.1979.30","article-title":"Thymectomy and cancer: a further report","volume":"39","author":"Vessey","year":"1979","journal-title":"Br. J. Cancer"},{"issue":"5","key":"10.1016\/j.critrevonc.2016.01.012_bib0960","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1212\/WNL.49.5.1454","article-title":"Paraneoplastic myasthenia gravis: detection of anti-MGT30 (titin) antibodies predicts thymic epithelial tumor","volume":"49","author":"Voltz","year":"1997","journal-title":"Neurology"},{"key":"10.1016\/j.critrevonc.2016.01.012_bib0965","series-title":"A SRC inhibitor, administered orally daily to patients with advanced thymic malignancies","article-title":"A phase II study of saracatinib (AZD0530)","author":"Wakelee","year":"2010"},{"issue":"2","key":"10.1016\/j.critrevonc.2016.01.012_bib0970","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1002\/1097-0142(19920715)70:2<443::AID-CNCR2820700212>3.0.CO;2-T","article-title":"Malignant thymoma","volume":"70","author":"Wang","year":"1992","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.critrevonc.2016.01.012_bib0975","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s004280050064","article-title":"p53 alterations in thymic epithelial tumours","volume":"431","author":"Weirich","year":"1997","journal-title":"Virchows Arch."},{"issue":"1","key":"10.1016\/j.critrevonc.2016.01.012_bib0980","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s00464-011-1879-7","article-title":"Robotic-assisted thymectomy is superior to transternal thymectomy","volume":"26","author":"Weksler","year":"2012","journal-title":"Surg. Endosc."},{"issue":"1","key":"10.1016\/j.critrevonc.2016.01.012_bib0985","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.athoracsur.2012.09.006","article-title":"Thymic carcinoma: a multivariate analysis of factors predictive of survival in 290 patients","volume":"95","author":"Weksler","year":"2013","journal-title":"Ann. Thorac. Surg."},{"issue":"9","key":"10.1016\/j.critrevonc.2016.01.012_bib0990","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1001\/jama.283.9.1142","article-title":"Association between thymoma and second neoplasms","volume":"283","author":"Welsh","year":"2000","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.critrevonc.2016.01.012_bib0995","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/ijc.11545","article-title":"Thymoma and subsequent cancers","volume":"108","author":"Welsh","year":"2004","journal-title":"Int. J. Cancer"},{"issue":"3","key":"10.1016\/j.critrevonc.2016.01.012_bib1000","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/S0003-4975(10)63114-1","article-title":"Thymoma: a continuing survey at the Massachusetts General Hospital","volume":"28","author":"Wilkins","year":"1979","journal-title":"Ann. Thorac. Surg."},{"issue":"3","key":"10.1016\/j.critrevonc.2016.01.012_bib1005","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/S0022-5223(19)43412-0","article-title":"Cases of thymoma at the Massachusetts General Hospital","volume":"52","author":"Wilkins","year":"1966","journal-title":"J. Thorac. Cardiovasc. Surg."},{"issue":"6","key":"10.1016\/j.critrevonc.2016.01.012_bib1010","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/0003-4975(91)90999-7","article-title":"Role of staging in prognosis and management of thymoma","volume":"51","author":"Wilkins","year":"1991","journal-title":"Ann. Thorac. Surg."},{"issue":"4","key":"10.1016\/j.critrevonc.2016.01.012_bib1015","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1097\/00000658-199910000-00012","article-title":"Clinical and pathological predictors of survival in patients with thymoma","volume":"2308","author":"Wilkins","year":"1999","journal-title":"Ann. Surg."},{"issue":"2","key":"10.1016\/j.critrevonc.2016.01.012_bib1020","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.athoracsur.2007.08.051","article-title":"Induction chemoradiotherapy followed by resection for locally advanced Masaoka stage III and IVA thymic tumors","volume":"85","author":"Wright","year":"2008","journal-title":"Ann. Thorac. Surg."},{"issue":"4","key":"10.1016\/j.critrevonc.2016.01.012_bib1025","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1016\/j.athoracsur.2006.05.028","article-title":"Pleuropneumonectomy for the treatment of Masaoka stage Iva thymoma","volume":"82","author":"Wright","year":"2006","journal-title":"Ann. Thorac. Surg."},{"issue":"1","key":"10.1016\/j.critrevonc.2016.01.012_bib1030","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/0003-4975(95)00983-3","article-title":"Surgical treatment for invasive thymoma, especially when the superior vena cava is invaded","volume":"61","author":"Yagi","year":"1996","journal-title":"Ann. Thorac. Surg."},{"issue":"2","key":"10.1016\/j.critrevonc.2016.01.012_bib1035","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.lungcan.2006.01.009","article-title":"Thymic carcinoma with epidermal growth factor receptor gene mutations","volume":"52","author":"Yamaguchi","year":"2006","journal-title":"Lung Cancer"},{"issue":"9","key":"10.1016\/j.critrevonc.2016.01.012_bib1040","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1002\/1097-0142(19911101)68:9<1984::AID-CNCR2820680923>3.0.CO;2-P","article-title":"A tentative tumor-node-metastasis classification of thymomas","volume":"68","author":"Yamakawa","year":"1991","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.critrevonc.2016.01.012_bib1045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.thorsurg.2010.08.008","article-title":"Prediction of thymoma histology and stage by radiographic criteria","volume":"21","author":"Yanagawa","year":"2011","journal-title":"Thorac. Surg. Clin."},{"key":"10.1016\/j.critrevonc.2016.01.012_bib1050","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1186\/1477-7819-11-157","article-title":"Video-assisted thoracoscopic surgery versus robotic-assisted thoracoscopic surgery in the surgical treatment of Masaoka syage I thymoma","volume":"11","author":"Ye","year":"2013","journal-title":"World J. Surg. Oncol."},{"key":"10.1016\/j.critrevonc.2016.01.012_bib1055","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.lungcan.2008.03.013","article-title":"Mutational status of EGFR and KIT in thymoma and thymic carcinoma","volume":"62","author":"Yoh","year":"2008","journal-title":"Lung Cancer"},{"issue":"1","key":"10.1016\/j.critrevonc.2016.01.012_bib1060","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0002-9440(10)64536-1","article-title":"Recurrent genetic aberrations in thymoma and thymic carcinoma","volume":"157","author":"Zettl","year":"2000","journal-title":"Am. J. Pathol."},{"issue":"4","key":"10.1016\/j.critrevonc.2016.01.012_bib1065","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1016\/j.ijrobp.2004.05.013","article-title":"Radiotherapy and prognostic factors for thymoma: a retrospective study of 175 patients","volume":"60","author":"Zhu","year":"2004","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"2","key":"10.1016\/j.critrevonc.2016.01.012_bib1070","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.athoracsur.2004.02.021","article-title":"Trans cervical subxiphoid videothoracoscopic maximal thymectomy. Operative technique and early results","volume":"78","author":"Zielinski","year":"2004","journal-title":"Ann. Thorac. Surg."},{"issue":"2","key":"10.1016\/j.critrevonc.2016.01.012_bib1075","first-page":"136","article-title":"Postoperative radiotherapy for a stage I thymoma: a prospective randomized trial in 29 cases","volume":"112","author":"Zuang","year":"1999","journal-title":"Chin. Med. J."},{"issue":"20","key":"10.1016\/j.critrevonc.2016.01.012_bib1080","doi-asserted-by":"crossref","first-page":"4686","DOI":"10.1002\/cncr.25367","article-title":"Insulinlike growth factor-1 receptor and phosphorylated AKT-serine 473 expression in 132 resected thymomas and thymic carcinomas","volume":"116","author":"Zucali","year":"2010","journal-title":"Cancer"}],"container-title":["Critical Reviews in Oncology\/Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842816300117?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842816300117?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,14]],"date-time":"2020-09-14T00:27:17Z","timestamp":1600043237000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1040842816300117"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":216,"alternative-id":["S1040842816300117"],"URL":"https:\/\/doi.org\/10.1016\/j.critrevonc.2016.01.012","relation":{},"ISSN":["1040-8428"],"issn-type":[{"value":"1040-8428","type":"print"}],"subject":[],"published":{"date-parts":[[2016,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Thymoma and thymic carcinomas","name":"articletitle","label":"Article Title"},{"value":"Critical Reviews in Oncology\/Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.critrevonc.2016.01.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}